Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
Trial details
- Registry ID
- NCT07010159
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387NCT07010159 | KNSA | Phase 2, Phase 3 | Recruiting | 2027-12-31Estimated |
| Transition to KPL-387 Monotherapy Dosing & Administration StudyNCT07288216 | KNSA | Phase 2 | Recruiting | 2027-12-31Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |